Corix Bioscience, Inc. (OTCPK: CXBS)
Health Care · Biotechnology · US
$—
— today · — 1Y
Corix Bioscience, Inc. (OTCPK: CXBS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $20.00 and employs 2 people.
trading between 0.00 and 0.00.
CXBS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $20.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 251.20
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 20.02M
- Employees
- 2
- Next earnings
- —
About Corix Bioscience, Inc.
Corix Bioscience, Inc. specializes in providing cannabidiol (CBD) oil, which is used for various medical applications. The company manages the full cycle of operations, from cultivating and harvesting industrial hemp plants to extracting the CBD oil. Formerly known as American Housing Income Trust, Inc., the organization rebranded as Corix Bioscience, Inc. in June 2017. Its corporate headquarters are situated in Phoenix, Arizona.
- Listed since
- Mar 14, 2017
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.